J&J | JNJ - Selling And Administration Expenses


J&J reported $6.03B in Selling and Administration Expenses for its fiscal quarter ending in March of 2026.





Selling And Administration Expenses Change Date
AbbVie USD 3.58B 316M Mar/2026
Abbott USD 3.27B 138M Mar/2026
Amgen USD 1.58B 354M Mar/2026
AstraZeneca USD 5.06B 455M Mar/2026
Baxter International USD 728M 33M Mar/2026
Bayer EUR 3.7B 356M Mar/2026
Becton, Dickinson and Co. USD 1.21B 180M Mar/2026
Biogen USD 554.3M 128.2M Mar/2026
Boston Scientific USD 1.78B 53M Mar/2026
Bristol-Myers Squibb USD 1.62B 564M Mar/2026
CONMED USD 141.7M 25.06M Mar/2026
Cooper Companies USD 676.2M 303.1M Mar/2026
Dexcom USD 349.7M 49.8M Mar/2026
Edwards Lifesciences USD 522.2M 80.7M Mar/2026
Eli Lilly USD 2.93B 198M Mar/2026
Gilead Sciences USD 1.45B 326M Mar/2026
GlaxoSmithKline GBP 2.12B 558M Mar/2026
Globus Medical USD 297.77M 20.7M Mar/2026
Insulet USD 317.2M 14.2M Mar/2026
Integra LifeSciences USD 178.24M 21.79M Mar/2026
Intuitive Surgical USD 613.3M 73.8M Mar/2026
J&J USD 6.03B 719M Mar/2026
Medtronic 2.96B 9M Dec/2025
Merck USD 2.67B 180M Mar/2026
Merit Medical Systems USD 110.47M 4.36M Mar/2026
Novartis USD 3.14B 296M Mar/2026
Pfizer USD 2.92B 1.16B Mar/2026
Regeneron Pharmaceuticals USD 647.7M 127.3M Mar/2026
Roche Holding CHF 7.28B 3.99B Dec/2025
Sanofi EUR 2.33B 419M Mar/2026
Stryker USD 2.15B 17M Mar/2026
Tandem Diabetes Care USD 99.86M 5.34M Dec/2025
Teva Pharmaceutical Industries USD 1000M 120M Mar/2026
Vertex Pharmaceuticals USD 493.7M 6.7M Mar/2026
Zimmer Biomet Holdings USD 849.9M 5.8M Mar/2026
Zoetis USD 588M 31M Mar/2026